Corticosteroids in status asthmaticus

Area of Science:

• Pediatric Pulmonology
• Critical Care Medicine
• Pharmacology

Background:

• Status asthmaticus is a severe form of asthma requiring hospitalization.
• Non-steroid-dependent children with status asthmaticus may benefit from various treatments.
• The role of corticosteroids in acute asthma exacerbations is debated.

Purpose of the Study:

• To evaluate the additive effect of corticosteroids on bronchodilator therapy in non-steroid-dependent children with status asthmaticus.
• To assess the impact of hydrocortisone on clinical improvement and lung function recovery.
• To determine if corticosteroids enhance airway responsiveness to salbutamol.

Main Methods:

• A randomized controlled trial involving 19 non-steroid-dependent children hospitalized with status asthmaticus.
• Participants were assigned to receive either intravenous hydrocortisone or a placebo.
• All participants received salbutamol inhalations and intravenous aminophylline therapy.

Main Results:

• Both groups showed significant improvement in clinical scores and peak expiratory flow rate (PEFR) within 36 hours.
• There was no statistically significant difference in the degree of improvement between the hydrocortisone and control groups.
• Corticosteroid therapy did not enhance the response to salbutamol or hasten recovery in this patient population.

Conclusions:

• In the initial 36 hours of treatment, corticosteroids offer no additional benefit to bronchodilator therapy (salbutamol and aminophylline) for non-steroid-dependent children in status asthmaticus.
• Corticosteroids do not appear to increase airway responsiveness to inhaled sympathomimetic drugs in this context.
• The study suggests that for short-term management of status asthmaticus in this group, corticosteroids may not be essential.